Bestzyme launches world's first automated sweet protein production line in Jinan
Bestzyme has completed the world's first dedicated, automated smart production line for sweet proteins at its Jinan facility, per a Sept. 22, 2026 PR Newswire release.
Wall Street Correspondent
JINAN, China — Sept. 22, 2026 — Bestzyme, a synthetic biology company operating under GenScript Biotech, announced the completion and launch of the world's first dedicated, automated smart production line for sweet proteins at its facility in Jinan, according to a PR Newswire release published on Sept. 22, 2026. The project establishes the industry's first full-chain automated manufacturing capacity for alternative sweet proteins, shifting the category from pilot-scale fermentation to industrial-volume output.
Strategic Context
The facility integrates continuous fermentation, automated downstream purification, and digital process control to lower unit production costs for sweet proteins. As consumer-goods manufacturers face sustained pressure to reformulate portfolios away from traditional cane sugar and high-fructose corn syrup, the availability of commercial-scale biological sweeteners addresses a primary supply-chain bottleneck. By housing the entire production sequence within a single dedicated smart line, Bestzyme aims to secure early-mover advantage in commercializing high-intensity, protein-based sweeteners for global food and beverage formulators.
Forward Outlook
Operators and allocators monitoring the synthetic biology sector should watch for subsequent commercial supply agreements and volume output metrics from the Jinan site. The operational efficiency and yield stability demonstrated on this first automated line will likely dictate capital expenditure timelines for subsequent industrial expansions across GenScript Biotech's manufacturing footprint.
Sophia Brennan
Wall Street Correspondent
Covers IPOs, buybacks, and the capital-markets calendar out of New York.
